Uma Sinha

4.4k total citations · 1 hit paper
109 papers, 2.9k citations indexed

About

Uma Sinha is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Uma Sinha has authored 109 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 31 papers in Molecular Biology and 28 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Uma Sinha's work include Blood Coagulation and Thrombosis Mechanisms (39 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). Uma Sinha is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (39 papers), Atrial Fibrillation Management and Outcomes (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). Uma Sinha collaborates with scholars based in United States, India and Canada. Uma Sinha's co-authors include Stanley J. Hollenbach, David R. Phillips, Francis DeGuzman, Pamela B. Conley, Athiwat Hutchaleelaha, Mayuko Inagaki, Genmin Lu, Mark J. Karbarz, Keith Abe and Peng Luan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Uma Sinha

104 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

2013 533 citations Genmin Lu, Francis DeGuzman et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Uma Sinha	1.2k	812	746	743	418	109	2.9k
Jean–Marie Stassen	602 0.5×	343 0.4×	802 1.1×	491 0.7×	146 0.3×	41	2.4k
Sven Nylander	1.4k 1.2×	569 0.7×	431 0.6×	415 0.6×	97 0.2×	52	2.6k
Stefano Manarini	423 0.4×	155 0.2×	485 0.7×	679 0.9×	315 0.8×	36	2.1k
Giuseppe G. Nenci	621 0.5×	433 0.5×	265 0.4×	491 0.7×	116 0.3×	100	1.9k
Jacques Himber	330 0.3×	423 0.5×	501 0.7×	1.1k 1.5×	260 0.6×	29	2.0k
Constantino Martı́nez	364 0.3×	157 0.2×	985 1.3×	891 1.2×	250 0.6×	101	2.8k
Yu Chen Barrett	1.3k 1.1×	847 1.0×	696 0.9×	231 0.3×	89 0.2×	25	2.9k
Ahmed Hasan	686 0.6×	114 0.1×	475 0.6×	450 0.6×	650 1.6×	46	2.5k
Gunnar Fager	859 0.7×	434 0.5×	692 0.9×	264 0.4×	56 0.1×	62	3.1k
Zhaoqing Wang	906 0.8×	327 0.4×	391 0.5×	227 0.3×	188 0.4×	46	2.1k

Countries citing papers authored by Uma Sinha

Since Specialization

Citations

This map shows the geographic impact of Uma Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uma Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uma Sinha more than expected).

Fields of papers citing papers by Uma Sinha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uma Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uma Sinha. The network helps show where Uma Sinha may publish in the future.

Co-authorship network of co-authors of Uma Sinha

This figure shows the co-authorship network connecting the top 25 collaborators of Uma Sinha. A scholar is included among the top collaborators of Uma Sinha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uma Sinha. Uma Sinha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masri, Ahmad, Mandar A. Aras, Daniel Jacoby, et al.. (2025). Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up. Journal of Cardiac Failure. 31(8). 1354–1359. 2 indexed citations

Davis, Margot K., Kevin Alexander, Amrut V. Ambardekar, et al.. (2025). ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. Journal of the American College of Cardiology. 85(12). 1663–1663.

Masri, Ahmad, Mandar A. Aras, Rodney H. Falk, et al.. (2024). Long-term Safety And Tolerability Of Acoramidis (AG10) In Symptomatic Transthyretin Amyloid Cardiomyopathy: 4-year Update From An Ongoing, Phase 2, Open-label Extension Study. Journal of Cardiac Failure. 30(1). 221–221. 3 indexed citations

Ji, Alan X., et al.. (2023). Acoramidis produces near-complete TTR stabilization in blood samples from patients with variant transthyretin amyloidosis that is greater than that achieved with tafamidis. European Heart Journal. 44(Supplement_2). 3 indexed citations

Masri, Ahmad, Mandar A. Aras, Rodney H. Falk, et al.. (2022). LONG-TERM SAFETY AND TOLERABILITY OF ACORAMIDIS (AG10) IN SYMPTOMATIC TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: UPDATED ANALYSIS FROM AN ONGOING PHASE 2 OPEN-LABEL EXTENSION STUDY. Journal of the American College of Cardiology. 79(9). 227–227. 2 indexed citations

Sinha, Uma, et al.. (2019). Effectiveness of Scapular Mobilization versus Myofascial Release of Subscapularis on Pain, ROM and Function in Subjects with Chronic Frozen Shoulder: A Comparative Study. International Journal of Health Sciences and Research. 9(8). 149–156. 4 indexed citations

Ji, Alan X., et al.. (2019). Abstract 13847: Differential Transthyretin Binding, Kinetic Stability and Additive Ex Vivo Stabilization by AG10 Compared to Tafamidis. Circulation. 1 indexed citations

Judge, Daniel P., Stephen B. Heitner, Rodney H. Falk, et al.. (2019). Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 74(3). 285–295. 180 indexed citations

Fox, Jonathan C., Jennifer Hellawell, Terry O’Reilly, et al.. (2019). First‐in‐Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers. Clinical Pharmacology in Drug Development. 9(1). 115–129. 41 indexed citations

10.

Fox, Jonathan C., Stephen B. Heitner, Rodney H. Falk, et al.. (2019). AG10 CONSISTENTLY STABILIZES TRANSTHYRETIN TO A HIGH LEVEL IN BOTH WILD TYPE AND MUTANT AMYLOID CARDIOMYOPATHY: RESPONDER ANALYSES FROM A PHASE 2 CLINICAL TRIAL. Journal of the American College of Cardiology. 73(9). 660–660. 2 indexed citations

11.

Miller, Mark R., Arindom Pal, Hyun Joo, et al.. (2018). Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis. Journal of Medicinal Chemistry. 61(17). 7862–7876. 66 indexed citations

12.

Sinha, Uma, et al.. (2013). Recurrent hypokalemic paralysis: An atypical presentation of hypothyroidism. Indian Journal of Endocrinology and Metabolism. 17(1). 174–176. 11 indexed citations

13.

Sinha, Uma, Joel Morganroth, Daniel D. Gretler, Stanley J. Hollenbach, & Joseph L. Lambing. (2013). ABSENCE OF QTC PROLONGATION WITH BETRIXABAN: A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND POSITIVE-CONTROLLED THOROUGH ECG STUDY. Journal of the American College of Cardiology. 61(10). E271–E271. 1 indexed citations

14.

Sinha, Uma, et al.. (2011). Human immunodeficiency virus endocrinopathy. Indian Journal of Endocrinology and Metabolism. 15(4). 251–260. 25 indexed citations

15.

Lu, Genmin, Francis DeGuzman, Stanley J. Hollenbach, et al.. (2010). Abstract 12420: Reversal of Low Molecular Weight Heparin and Fondaparinux by a Recombinant Antidote (r-Antidote, PRT064445). Circulation. 122. 8 indexed citations

16.

Jia, Zhaozhong J., Robert M. Scarborough, Penglie Zhang, et al.. (2009). Design, Synthesis and Discovery of 1-(2-(6-Chloro-3-methylsulfonyl)-naphthyl)-1H-pyrazole-5-carboxylamides as Highly Potent Factor Xa Inhibitors. Chemical and Pharmaceutical Bulletin. 57(9). 1004–1007. 2 indexed citations

17.

Zhang, Penglie, Liang Bao, Zhaozhong J. Jia, et al.. (2009). Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR. Bioorganic & Medicinal Chemistry Letters. 19(8). 2186–2189. 10 indexed citations

18.

Huang, Wenrong, Penglie Zhang, Lingyan Wang, et al.. (2003). Design, synthesis and structure–Activity relationships of benzoxazinone-Based factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(3). 561–566. 18 indexed citations

19.

Song, Yonghong, Lane A. Clizbe, Willy Teng, et al.. (2002). Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modification. Bioorganic & Medicinal Chemistry Letters. 12(15). 2043–2046. 30 indexed citations

20.

Zhu, Bing‐Yan, Wenrong Huang, Ting Su, et al.. (2001). Discovery of Transition State Factor Xa Inhibitors as Potential Anticoagulant Agents. Current Topics in Medicinal Chemistry. 1(2). 101–119. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact